Healthcare
-
Insulin prices plunge for Granite Staters due to Biden’s American Rescue Plan
Eli Lilly, Sanofi, and Novo Nordisk’s price cuts are expected to benefit many Granite Staters who need insulin to survive. The companies first announced the moves last year, as a response to an American Rescue Plan provision that threatened to penalize them if they kept prices high.
-
Op-ed: I’m not your political weapon
I’m a trans woman and I’m happy, it’s really that simple. I recently graduated from college with a mechanical engineering degree and I’m now working as an aerospace engineer in the Seacoast area. I just finished applying to graduate school, and I’m excited about my future career. I’ve happily moved in with my boyfriend recently,…
-
To lower the cost of expensive drugs, Biden targets Big Pharma’s patents
Under a plan announced Thursday, the government would consider overriding the patent for high-priced drugs that have been developed with the help of taxpayer money and letting competitors make them in hopes of driving down the cost.
-
Sen. Shaheen pushes forward bill to reduce insulin costs
The Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2023 would “comprehensively address the skyrocketing costs of insulin.”
-
A new RSV shot for infants is in short supply
A new shot for infants against RSV is in short supply, and U.S. health officials told doctors they should prioritize giving the drug to babies at the highest risk of severe disease.
-
What to know as fall vaccinations against get underway
For the first time, the U.S. has vaccines to fight a trio of viruses that cause fall and winter misery. But health officials worry that shot fatigue and hassles in getting them will leave too many people needlessly unprotected.
